Whitcup Scott M 4
4 · Adverum Biotechnologies, Inc. · Filed Jun 20, 2024
Insider Transaction Report
Form 4
Whitcup Scott M
Director
Transactions
- Award
Stock Option (Right to Buy)
2024-06-17+10,520→ 10,520 totalExercise: $7.32Exp: 2034-06-16→ Common Stock (10,520 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable on the earlier of June 17, 2025 or the 2025 annual meeting of stockholders, subject to (1) accelerated vesting upon a change of control and (2) the Reporting Person's continued service with the Issuer on the vesting date.